509 related articles for article (PubMed ID: 22583565)
1. Natural antimicrobial peptides from bacteria: characteristics and potential applications to fight against antibiotic resistance.
Hassan M; Kjos M; Nes IF; Diep DB; Lotfipour F
J Appl Microbiol; 2012 Oct; 113(4):723-36. PubMed ID: 22583565
[TBL] [Abstract][Full Text] [Related]
2. Bacteriocins: Classification, synthesis, mechanism of action and resistance development in food spoilage causing bacteria.
Kumariya R; Garsa AK; Rajput YS; Sood SK; Akhtar N; Patel S
Microb Pathog; 2019 Mar; 128():171-177. PubMed ID: 30610901
[TBL] [Abstract][Full Text] [Related]
3. Bacteriocins - a viable alternative to antibiotics?
Cotter PD; Ross RP; Hill C
Nat Rev Microbiol; 2013 Feb; 11(2):95-105. PubMed ID: 23268227
[TBL] [Abstract][Full Text] [Related]
4. Antimicrobial peptides and bacteriocins: alternatives to traditional antibiotics.
Sang Y; Blecha F
Anim Health Res Rev; 2008 Dec; 9(2):227-35. PubMed ID: 18983725
[TBL] [Abstract][Full Text] [Related]
5. Bacteriocin-based strategies for food biopreservation.
Gálvez A; Abriouel H; López RL; Ben Omar N
Int J Food Microbiol; 2007 Nov; 120(1-2):51-70. PubMed ID: 17614151
[TBL] [Abstract][Full Text] [Related]
6. Alternatives to antibiotics: bacteriocins, antimicrobial peptides and bacteriophages.
Joerger RD
Poult Sci; 2003 Apr; 82(4):640-7. PubMed ID: 12710486
[TBL] [Abstract][Full Text] [Related]
7. Staphylococcal-Produced Bacteriocins and Antimicrobial Peptides: Their Potential as Alternative Treatments for
Newstead LL; Varjonen K; Nuttall T; Paterson GK
Antibiotics (Basel); 2020 Jan; 9(2):. PubMed ID: 31973108
[No Abstract] [Full Text] [Related]
8. Genetically engineered bacteriocins and their potential as the next generation of antimicrobials.
Gillor O; Nigro LM; Riley MA
Curr Pharm Des; 2005; 11(8):1067-75. PubMed ID: 15777256
[TBL] [Abstract][Full Text] [Related]
9. The food safety perspective of antibiotic resistance.
McDermott PF; Zhao S; Wagner DD; Simjee S; Walker RD; White DG
Anim Biotechnol; 2002 May; 13(1):71-84. PubMed ID: 12212946
[TBL] [Abstract][Full Text] [Related]
10. Overview of ribosomal and non-ribosomal antimicrobial peptides produced by Gram positive bacteria.
Tajbakhsh M; Karimi A; Fallah F; Akhavan MM
Cell Mol Biol (Noisy-le-grand); 2017 Oct; 63(10):20-32. PubMed ID: 29096754
[TBL] [Abstract][Full Text] [Related]
11. Are bacteriocins underexploited? Novel applications for old antimicrobials.
Montalbán-López M; Sánchez-Hidalgo M; Valdivia E; Martínez-Bueno M; Maqueda M
Curr Pharm Biotechnol; 2011 Aug; 12(8):1205-20. PubMed ID: 21470151
[TBL] [Abstract][Full Text] [Related]
12. Antimicrobial peptides as promising antibiotic adjuvants to combat drug-resistant pathogens.
Chen C; Shi J; Wang D; Kong P; Wang Z; Liu Y
Crit Rev Microbiol; 2024 May; 50(3):267-284. PubMed ID: 36890767
[TBL] [Abstract][Full Text] [Related]
13. Bacteriocins, Potent Antimicrobial Peptides and the Fight against Multi Drug Resistant Species: Resistance Is Futile?
Meade E; Slattery MA; Garvey M
Antibiotics (Basel); 2020 Jan; 9(1):. PubMed ID: 31963311
[TBL] [Abstract][Full Text] [Related]
14. Bacillus sp. Bacteriocins: Natural Weapons against Bacterial Enemies.
Vaca J; Ortiz A; Sansinenea E
Curr Med Chem; 2022; 29(12):2093-2108. PubMed ID: 34047258
[TBL] [Abstract][Full Text] [Related]
15. Biological properties and production of bacteriocins-like-inhibitory substances by Lactobacillus sp. strains from human vagina.
Fuochi V; Cardile V; Petronio Petronio G; Furneri PM
J Appl Microbiol; 2019 May; 126(5):1541-1550. PubMed ID: 30499608
[TBL] [Abstract][Full Text] [Related]
16. Bacteriocins: Recent Advances in its Application as an Antimicrobial Alternative.
Fathizadeh H; Pakdel F; Saffari M; Esmaeili D; Heravi MM; Dao S; Ganbarov K; Kafil HS
Curr Pharm Biotechnol; 2022; 23(8):1028-1040. PubMed ID: 34493194
[TBL] [Abstract][Full Text] [Related]
17. Class II antimicrobial peptides from lactic acid bacteria.
Nes IF; Holo H
Biopolymers; 2000; 55(1):50-61. PubMed ID: 10931441
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of bacteriocinogenic activity, safety traits and biotechnological potential of fecal lactic acid bacteria (LAB), isolated from Griffon Vultures (Gyps fulvus subsp. fulvus).
Arbulu S; Jiménez JJ; Gútiez L; Campanero C; Del Campo R; Cintas LM; Herranz C; Hernández PE
BMC Microbiol; 2016 Sep; 16(1):228. PubMed ID: 27688001
[TBL] [Abstract][Full Text] [Related]
19. Antimicrobial Peptides: Features, Action, and Their Resistance Mechanisms in Bacteria.
Moravej H; Moravej Z; Yazdanparast M; Heiat M; Mirhosseini A; Moosazadeh Moghaddam M; Mirnejad R
Microb Drug Resist; 2018; 24(6):747-767. PubMed ID: 29957118
[TBL] [Abstract][Full Text] [Related]
20. Synergy between novel antimicrobials and conventional antibiotics or bacteriocins.
Wolska KI; Grześ K; Kurek A
Pol J Microbiol; 2012; 61(2):95-104. PubMed ID: 23163208
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
